1. Home
  2. BNTC vs CADL Comparison

BNTC vs CADL Comparison

Compare BNTC & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNTC
  • CADL
  • Stock Information
  • Founded
  • BNTC 1995
  • CADL 1999
  • Country
  • BNTC United States
  • CADL United States
  • Employees
  • BNTC N/A
  • CADL N/A
  • Industry
  • BNTC Biotechnology: Pharmaceutical Preparations
  • CADL Biotechnology: Pharmaceutical Preparations
  • Sector
  • BNTC Health Care
  • CADL Health Care
  • Exchange
  • BNTC Nasdaq
  • CADL Nasdaq
  • Market Cap
  • BNTC 365.1M
  • CADL 313.5M
  • IPO Year
  • BNTC N/A
  • CADL 2021
  • Fundamental
  • Price
  • BNTC $13.78
  • CADL $4.89
  • Analyst Decision
  • BNTC Strong Buy
  • CADL Strong Buy
  • Analyst Count
  • BNTC 5
  • CADL 5
  • Target Price
  • BNTC $24.80
  • CADL $19.80
  • AVG Volume (30 Days)
  • BNTC 36.4K
  • CADL 707.2K
  • Earning Date
  • BNTC 11-13-2025
  • CADL 11-13-2025
  • Dividend Yield
  • BNTC N/A
  • CADL N/A
  • EPS Growth
  • BNTC N/A
  • CADL N/A
  • EPS
  • BNTC N/A
  • CADL N/A
  • Revenue
  • BNTC N/A
  • CADL N/A
  • Revenue This Year
  • BNTC N/A
  • CADL N/A
  • Revenue Next Year
  • BNTC N/A
  • CADL N/A
  • P/E Ratio
  • BNTC N/A
  • CADL N/A
  • Revenue Growth
  • BNTC N/A
  • CADL N/A
  • 52 Week Low
  • BNTC $8.20
  • CADL $3.79
  • 52 Week High
  • BNTC $17.15
  • CADL $14.60
  • Technical
  • Relative Strength Index (RSI)
  • BNTC 57.09
  • CADL 35.32
  • Support Level
  • BNTC $13.49
  • CADL $4.60
  • Resistance Level
  • BNTC $14.05
  • CADL $5.01
  • Average True Range (ATR)
  • BNTC 0.56
  • CADL 0.29
  • MACD
  • BNTC -0.01
  • CADL -0.03
  • Stochastic Oscillator
  • BNTC 64.92
  • CADL 16.88

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Share on Social Networks: